CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection

Youn Jae Lee, Jeong Heo, Do Young Kim, Woo Jin Chung, Won Young Tak, Yoon Jun Kim, Seung Woon Paik, Eungeol Sim, Susila Kulasingam, Rohit Talwani, Barbara Haber, Peggy Hwang

Clin Mol Hepatol. 2019;25(4):400-407. Published online 2019 May 28 DOI: https://doi.org/10.3350/cmh.2019.0006

Elbasvir/grazoprevir

Reactions Weekly. 2019;1740(1):138-138

Link1 Link2

Link3

Cost-Effectiveness of Elbasvir/Grazoprevir Versus Daclatasvir Plus Asunaprevir in Patients with Chronic Hepatitis C Virus Genotype 1b Infection in China

Pingyu Chen, Aixia Ma, Qiang Liu

Clinical Drug Investigation. 2018;38(11):1031-1039

Link1 Link2

Link3

FRI-248-Cost-effectiveness of elbasvir/grazoprevir (EBR/GZR) for treatment-naive (TN) patients with chronic hepatitis C virus (HCV) genotype 1b (GT1b) infection in Russia

Shelby Corman, Amy Puenpatom, Andrey Kulikov, Roza Yagudina

Journal of Hepatology. 2019;70(1):e503-e504

Link1 Link2

An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection

Youn Jae Lee, Jeong Heo, Do Young Kim, Woo Jin Chung, Won Young Tak, Yoon Jun Kim, Seung Woon Paik, Eungeol Sim, Susila Kulasingam, Rohit Talwani, Barbara Haber, Peggy Hwang

Clinical and Molecular Hepatology. 2019;25(4):400-407

Link1

Link2 Link3

The Cost-Effectiveness Analysis of Elbasvir/Grazoprevir Versus Peginterferon Αlpha-2A in Combination with Ribavirin in Patients with Chronic Hepatitis C Genotype 1b Infection in China

PY Chen, Q Liu, HC Li, AX Ma

Value in Health. 2018;21:S65

Link1 Link2

Treatment with Grazoprevir/Elbasvir in Post-kidney Transplant Patients with Hepatitis C Virus Genotype 4 Infection

Faisal Abaalkhail, Waleed Al-hamoudi, Ibrahim Altraif, Hazem Mohamed, Hassan Aleid, Dieter Broering, Saleh Alqahtani

Hepatitis Monthly. 2021;21(4):

Link1 Link2

Tu1504 – Effectiveness of Elbasvir/Grazoprevir in Patients with Hepatitis C Virus Genotype 1 Infection Receiving Dialysis

Amy Puenpatom, Jennifer R. Kramer, Yumei Cao, Hashem B. El-Serag, Fasiha Kanwal

Gastroenterology. 2019;156(6):S-1346

Link1 Link2

THU-171-Effectiveness of elbasvir/grazoprevir in patients with hepatitis C virus genotype 1 infection receiving dialysis

Jennifer Kramer, Amy Puenpatom, Yumei Cao, Hashem El-Serag, Fasiha Kanwal

Journal of Hepatology. 2019;70(1):e237

Link1 Link2

Projected impact of elbasvir/grazoprevir in patients with hepatitis C virus genotype 1 and chronic kidney disease in Vietnam

Chizoba Nwankwo, Shelby L. Corman, Elamin H. Elbasha

Journal of Infection and Public Health. 2019;12(4):502-508

Link1 Link2

The accuracy of baseline viral load for predicting the efficacy of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1a infection: An integrated analysis

Lawrence Serfaty, Ira Jacobson, Jürgen Rockstroh, Frederick L. Altice, Peggy Hwang, Eliav Barr, Michael Robertson, Barbara Haber

Journal of Viral Hepatitis. 2019;26(3):329-336

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.